Literature DB >> 29572643

Novel Mapping Strategies for Ventricular Tachycardia Ablation.

Zaid Aziz1, Roderick Tung2.   

Abstract

Despite advances in antiarrhythmic and device therapy, ventricular tachycardia (VT) continues to be a major cause of increased morbidity and mortality. During scar-mediated monomorphic ventricular tachycardia ablation, the search for critical isthmus sites continues to be the primary goal during successful ablative procedures. However, given the overwhelming hemodynamic instability of most ventricular arrhythmias (> 70%), VT ablation is increasingly performed during sinus rhythm. This technique requires either a greater reliance on isthmus surrogates, or more extensive ablation techniques and is a more probabilistic approach to substrate modification. We believe that a better understanding of scar physiology and activation during sinus rhythm has important implications for clinical workflow and mechanistic improvements with current ablation strategies. With advancements in high-density mapping and multi-electrode catheter technology, mapping of VT substrates is performed with higher resolution, with improved visualization of local abnormal ventricular activities (LAVA), and with a more nuanced functional understanding of late potentials. As a prerequisite, our practice for VT ablation starts with a high-density structural map to identify voltage abnormalities as well as an isochronal functional map of sinus rhythm activation to identify region of discontinuous wavefront propagation. As the era of increased automation has emerged, there continues to be vast array of customizable features, and we have adopted the use of multiple wavefront mapping to further elucidate possible arrhythmogenic substrate. Our emerging understanding of how scar propagation patterns relate to areas of abnormal signals and critical isthmuses may greatly improve the ability to identify surrogates during sinus rhythm and help localize the most arrhythmogenic regions within a given scar. In the hemodynamically unstable patients, we routinely integrate isochronal late activation mapping (ILAM) to identify areas of slow conduction to initiate our targeted ablation and substrate modification. Multi-electrode delineation of the entire reentrant VT circuit has value in understanding the size of the circuit, rotational nature, and transmural extent of human reentry. Correlative studies between the activation of the complete VT circuit and sinus rhythm are likely to provide important mechanistic insights on where fixed and/or functional block occurs within a complex scar substrate.

Entities:  

Keywords:  Functional mapping; Mapping; Ventricular tachycardia

Year:  2018        PMID: 29572643     DOI: 10.1007/s11936-018-0615-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  41 in total

1.  Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation.

Authors:  Antonio Berruezo; Juan Fernández-Armenta; David Andreu; Diego Penela; Csaba Herczku; Reinder Evertz; Laura Cipolletta; Juan Acosta; Roger Borràs; Elena Arbelo; Jose María Tolosana; Josep Brugada; Lluis Mont
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-01-12

2.  Accuracy of combined endocardial and epicardial electroanatomic mapping of a reperfused porcine infarct model: a comparison of electrofield and magnetic systems with histopathologic correlation.

Authors:  Roderick Tung; Shiro Nakahara; Rafael Ramirez; Dorina Gui; Clara Magyar; Chi Lai; Michael Fishbein; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2010-11-04       Impact factor: 6.343

3.  High-density mapping of ventricular scar: a comparison of ventricular tachycardia (VT) supporting channels with channels that do not support VT.

Authors:  Sachin Nayyar; Lauren Wilson; Anand N Ganesan; Thomas Sullivan; Pawel Kuklik; Darius Chapman; Anthony G Brooks; Rajiv Mahajan; Mathias Baumert; Glenn D Young; Prashanthan Sanders; Kurt C Roberts-Thomson
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-01-01

4.  Substrate characterization and catheter ablation in patients with scar-related ventricular tachycardia using ultra high-density 3-D mapping.

Authors:  Jana M Nührich; Lukas Kaiser; Ruken Özge Akbulak; Benjamin N Schäffer; Christian Eickholt; Michael Schwarzl; Pawel Kuklik; Julia Moser; Mario Jularic; Stephan Willems; Christian Meyer
Journal:  J Cardiovasc Electrophysiol       Date:  2017-07-03

5.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy.

Authors:  F E Marchlinski; D J Callans; C D Gottlieb; E Zado
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

6.  Impact of Electrode Type on Mapping of Scar-Related VT.

Authors:  Benjamin Berte; Jatin Relan; Frederic Sacher; Xavier Pillois; Anthony Appetiti; Seigo Yamashita; Saagar Mahida; Frederic Casassus; Darren Hooks; Jean-Marc Sellal; Sana Amraoui; Arnaud Denis; Nicolas Derval; Hubert Cochet; Mélèze Hocini; Michel Haïssaguerre; Rukshen Weerasooriya; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2015-09-10

Review 7.  Substrate mapping and ablation for ventricular tachycardia: the LAVA approach.

Authors:  Frederic Sacher; Han S Lim; Nicolas Derval; Arnaud Denis; Benjamin Berte; Seigo Yamashita; Mélèze Hocini; Michel Haissaguerre; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2014-12-02

8.  Relationship between voltage map "channels" and the location of critical isthmus sites in patients with post-infarction cardiomyopathy and ventricular tachycardia.

Authors:  Stavros E Mountantonakis; Robert E Park; David S Frankel; Mathew D Hutchinson; Sanjay Dixit; Joshua Cooper; David Callans; Francis E Marchlinski; Edward P Gerstenfeld
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

9.  Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia.

Authors:  Pierre Jaïs; Philippe Maury; Paul Khairy; Frédéric Sacher; Isabelle Nault; Yuki Komatsu; Mélèze Hocini; Andrei Forclaz; Amir S Jadidi; Rukshen Weerasooryia; Ashok Shah; Nicolas Derval; Hubert Cochet; Sebastien Knecht; Shinsuke Miyazaki; Nick Linton; Lena Rivard; Matthew Wright; Stephen B Wilton; Daniel Scherr; Patrizio Pascale; Laurent Roten; Michala Pederson; Pierre Bordachar; François Laurent; Steven J Kim; Philippe Ritter; Jacques Clementy; Michel Haïssaguerre
Journal:  Circulation       Date:  2012-04-04       Impact factor: 29.690

10.  The use of a novel signal analysis to identify the origin of idiopathic right ventricular outflow tract ventricular tachycardia during sinus rhythm: Simultaneous amplitude frequency electrogram transformation mapping.

Authors:  Abigail Louise D Te; Satoshi Higa; Fa-Po Chung; Chin-Yu Lin; Men-Tzung Lo; Che-An Liu; Chen Lin; Yi-Chung Chang; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Tze-Fan Chao; Jonan Liao; Yao-Ting Chang; Chung-Hsing Lin; Yuan Hung; Shinya Yamada; Kuo-Li Pan; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

View more
  3 in total

Review 1.  Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Authors:  Fa Po Chung; Chin Yu Lin; Yenn Jiang Lin; Shih Lin Chang; Li Wei Lo; Yu Feng Hu; Ta Chuan Tuan; Tze Fan Chao; Jo Nan Liao; Ting Yung Chang; Shih Ann Chen
Journal:  Korean Circ J       Date:  2018-10       Impact factor: 3.243

2.  Spectral characterisation of ventricular intracardiac potentials in human post-ischaemic bipolar electrograms.

Authors:  Giulia Baldazzi; Marco Orrù; Giuliana Solinas; Mirko Matraxia; Graziana Viola; Danilo Pani
Journal:  Sci Rep       Date:  2022-03-21       Impact factor: 4.379

3.  Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia: Single Center First Experiences.

Authors:  Ian J Gerard; Martin Bernier; Tarek Hijal; Neil Kopek; Piotr Pater; Jordan Stosky; Gabriela Stroian; Bruno Toscani; Joanne Alfieri
Journal:  Adv Radiat Oncol       Date:  2021-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.